Box–Behnken Design of Experiments of Polycaprolactone Nanoparticles Loaded with Irinotecan Hydrochloride

Background: The Box–Behnken design of experiments (BBD) is a statistical modelling technique that allows the determination of the significant factors in developing nanoparticles (NPs) using a limited number of runs. It also allows the prediction of the best levels of variables to obtain the desired...

Full description

Bibliographic Details
Main Authors: Basant Salah Mahmoud, Christopher McConville
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/4/1271
_version_ 1797603785993879552
author Basant Salah Mahmoud
Christopher McConville
author_facet Basant Salah Mahmoud
Christopher McConville
author_sort Basant Salah Mahmoud
collection DOAJ
description Background: The Box–Behnken design of experiments (BBD) is a statistical modelling technique that allows the determination of the significant factors in developing nanoparticles (NPs) using a limited number of runs. It also allows the prediction of the best levels of variables to obtain the desired characteristics (size, charge, and encapsulation efficiency) of the NPs. The aim of this study was to examine the effect of the independent variables (amount of polymer and drug, and surfactant concentration) and their interaction on the characteristics of the irinotecan hydrochloride (IRH)-loaded polycaprolactone (PCL) NPs and to determine the most optimum conditions for producing the desired NPs. Methods: The development of the NPs was carried out by a double emulsion solvent evaporation technique with yield enhancement. The NPs data were fitted in Minitab software to obtain the best fit model. Results: By using BBD, the most optimum conditions for producing the smallest size, highest magnitude of charge, and highest EE% of PCL NPs were predicted to be achieved by using 61.02 mg PCL, 9 mg IRH, and 4.82% PVA, which would yield 203.01 nm, −15.81 mV, and 82.35% EE. Conclusion: The analysis by BBD highlighted that the model was a good fit to the data, confirming the suitability of the design of the experiments.
first_indexed 2024-03-11T04:37:59Z
format Article
id doaj.art-1d8d4a1f48db47ab97b5623d704928e5
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-11T04:37:59Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-1d8d4a1f48db47ab97b5623d704928e52023-11-17T20:55:08ZengMDPI AGPharmaceutics1999-49232023-04-01154127110.3390/pharmaceutics15041271Box–Behnken Design of Experiments of Polycaprolactone Nanoparticles Loaded with Irinotecan HydrochlorideBasant Salah Mahmoud0Christopher McConville1School of Pharmacy, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UKSchool of Pharmacy, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UKBackground: The Box–Behnken design of experiments (BBD) is a statistical modelling technique that allows the determination of the significant factors in developing nanoparticles (NPs) using a limited number of runs. It also allows the prediction of the best levels of variables to obtain the desired characteristics (size, charge, and encapsulation efficiency) of the NPs. The aim of this study was to examine the effect of the independent variables (amount of polymer and drug, and surfactant concentration) and their interaction on the characteristics of the irinotecan hydrochloride (IRH)-loaded polycaprolactone (PCL) NPs and to determine the most optimum conditions for producing the desired NPs. Methods: The development of the NPs was carried out by a double emulsion solvent evaporation technique with yield enhancement. The NPs data were fitted in Minitab software to obtain the best fit model. Results: By using BBD, the most optimum conditions for producing the smallest size, highest magnitude of charge, and highest EE% of PCL NPs were predicted to be achieved by using 61.02 mg PCL, 9 mg IRH, and 4.82% PVA, which would yield 203.01 nm, −15.81 mV, and 82.35% EE. Conclusion: The analysis by BBD highlighted that the model was a good fit to the data, confirming the suitability of the design of the experiments.https://www.mdpi.com/1999-4923/15/4/1271polycaprolactoneirinotecan hydrochloridenanoparticlesBox–Behnkendesign of experimentsyield
spellingShingle Basant Salah Mahmoud
Christopher McConville
Box–Behnken Design of Experiments of Polycaprolactone Nanoparticles Loaded with Irinotecan Hydrochloride
Pharmaceutics
polycaprolactone
irinotecan hydrochloride
nanoparticles
Box–Behnken
design of experiments
yield
title Box–Behnken Design of Experiments of Polycaprolactone Nanoparticles Loaded with Irinotecan Hydrochloride
title_full Box–Behnken Design of Experiments of Polycaprolactone Nanoparticles Loaded with Irinotecan Hydrochloride
title_fullStr Box–Behnken Design of Experiments of Polycaprolactone Nanoparticles Loaded with Irinotecan Hydrochloride
title_full_unstemmed Box–Behnken Design of Experiments of Polycaprolactone Nanoparticles Loaded with Irinotecan Hydrochloride
title_short Box–Behnken Design of Experiments of Polycaprolactone Nanoparticles Loaded with Irinotecan Hydrochloride
title_sort box behnken design of experiments of polycaprolactone nanoparticles loaded with irinotecan hydrochloride
topic polycaprolactone
irinotecan hydrochloride
nanoparticles
Box–Behnken
design of experiments
yield
url https://www.mdpi.com/1999-4923/15/4/1271
work_keys_str_mv AT basantsalahmahmoud boxbehnkendesignofexperimentsofpolycaprolactonenanoparticlesloadedwithirinotecanhydrochloride
AT christophermcconville boxbehnkendesignofexperimentsofpolycaprolactonenanoparticlesloadedwithirinotecanhydrochloride